Susquehanna International Group
PRAX icon

Susquehanna International Group’s Praxis Precision Medicines PRAX Stock Holding History

Susquehanna International Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.1M Sell
99,700
-51,000
-34% -$15.8M ﹤0.01% 1670
2025
Q4 		$44.4M Buy
150,700
+69,100
+85% +$12.9M 0.01% 1463
2025
Q3 		$4.32M Sell
81,600
-21,200
-21% -$1.03M ﹤0.01% 4320
2025
Q2 		$4.32M Sell
102,800
-18,200
-15% -$693K ﹤0.01% 4256
2025
Q1 		$4.58M Sell
121,000
-6,600
-5% -$412K ﹤0.01% 3813
2024
Q4 		$9.82M Buy
127,600
+40,000
+46% +$2.89M ﹤0.01% 2690
2024
Q3 		$5.04M Sell
87,600
-79,500
-48% -$4.29M ﹤0.01% 3574
2024
Q2 		$6.91M Buy
167,100
+155,200
+1,304% +$7.33M ﹤0.01% 2952
2024
Q1 		$726K Buy
+11,900
New +$534K ﹤0.01% 7621
2023
Q2 		– Sell
-12,647
Closed -$154K – 12901
2023
Q1 		$154K Buy
+12,647
New +$534K ﹤0.01% 10893
2022
Q3 		– Sell
-3,027
Closed -$111K – 13922
2022
Q2 		$111K Buy
+3,027
New +$323K ﹤0.01% 11381
2021
Q3 		– Sell
-860
Closed -$236K – 13374
2021
Q2 		$236K Buy
+860
New +$308K ﹤0.01% 11250

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Susquehanna International Group's PRAX Position: Q1 2026 in Review

Susquehanna International Group increased its Praxis Precision Medicines (PRAX) stake by 264% in Q1 2026, buying an estimated $1.91M and bringing the position to 8,517 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #5454.

Susquehanna International Group first reported a position in PRAX in Q4 2021 and has held it in 17 quarters since. The position peaked at $12.2M in Q4 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Susquehanna International Group held 8,517 shares of Praxis Precision Medicines worth $2.74M as of Q1 2026.
  • Susquehanna International Group bought 6,174 Praxis Precision Medicines shares in Q1 2026, an estimated $1.91M.
  • Praxis Precision Medicines made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5454 holding.
  • Susquehanna International Group first reported a position in Praxis Precision Medicines in Q4 2021 and has held it in 17 quarters since.
  • Susquehanna International Group's Praxis Precision Medicines position peaked at $12.2M in Q4 2024.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.